These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


709 related items for PubMed ID: 25547322

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X.
    Int J Cancer; 2010 Jul 01; 127(1):118-26. PubMed ID: 19876917
    [Abstract] [Full Text] [Related]

  • 3. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X.
    Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225
    [Abstract] [Full Text] [Related]

  • 4. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY.
    J Exp Clin Cancer Res; 2015 Aug 22; 34(1):86. PubMed ID: 26297223
    [Abstract] [Full Text] [Related]

  • 8. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X, Stock C, Burwinkel B, Brenner H.
    PLoS One; 2013 Aug 22; 8(5):e62880. PubMed ID: 23690963
    [Abstract] [Full Text] [Related]

  • 9. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
    Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J, Xie H, Xu Y, Zeng X.
    Biochem Biophys Res Commun; 2014 Nov 07; 454(1):210-4. PubMed ID: 25450382
    [Abstract] [Full Text] [Related]

  • 10. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 07; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 11. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X, Wu Y, Ji M, Zhang S.
    Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115212
    [Abstract] [Full Text] [Related]

  • 12. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
    Yamada A, Horimatsu T, Okugawa Y, Nishida N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, Higurashi T, Yukawa N, Amanuma Y, Kikuchi O, Muto M, Ueno Y, Nakajima A, Chiba T, Boland CR, Goel A.
    Clin Cancer Res; 2015 Sep 15; 21(18):4234-42. PubMed ID: 26038573
    [Abstract] [Full Text] [Related]

  • 13. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.
    PLoS One; 2012 Sep 15; 7(9):e44398. PubMed ID: 22970209
    [Abstract] [Full Text] [Related]

  • 14. [Study on miR-490-5p and miR-363 as novel biomarkers for the diagnosis of colorectal cancer].
    Xu X, Wu X, Wu S, Jiang Q, Liu H, Chen R, Sun Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan 15; 17(1):45-50. PubMed ID: 24519049
    [Abstract] [Full Text] [Related]

  • 15. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV, Galbraith NJ, Yang D, Burton JF, Walker SP, Galandiuk S.
    Br J Cancer; 2017 Mar 14; 116(6):762-774. PubMed ID: 28152545
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY, Chen CC, Chang YS, Tsai WS, You JF, Lin GP, Chen TW, Chen JS, Chan EC.
    Oncotarget; 2016 Mar 01; 7(9):10663-75. PubMed ID: 26848774
    [Abstract] [Full Text] [Related]

  • 17. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A, Galandiuk S.
    Ann Surg; 2013 Sep 01; 258(3):400-8. PubMed ID: 24022433
    [Abstract] [Full Text] [Related]

  • 18. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
    Wang Q, Zhang H, Shen X, Ju S.
    Ann Clin Biochem; 2017 Jan 01; 54(1):76-85. PubMed ID: 27126269
    [Abstract] [Full Text] [Related]

  • 19. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY, Zhao XJ, Yu ZF, Hu FL, Liu YP, Cui BB, Dong XS, Zhao YS.
    Int J Clin Exp Pathol; 2015 Jan 01; 8(6):7092-101. PubMed ID: 26261602
    [Abstract] [Full Text] [Related]

  • 20. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A, Pericay C, Quílez ME, Ramírez-Lázaro MJ, Calvet X, Lario S.
    Anal Biochem; 2015 Nov 01; 488():28-35. PubMed ID: 26271186
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.